NEDD4L and familial pancreatic carcinoma: Lee et al. reported that NEDD4L inhibited autophagy and mitochondrial metabolism by downregulating the expression of ULK1 or ASCT2, thereby inhibiting the growth and survival of pancreatic cancer cells.